Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thioredoxin domain containing 17 pseudogene (TD17P)
- Target
- TD17P
- Molecular classification
- Pseudogene, Homolog of the thioredoxin domain-containing family
01
Overview
Thioredoxin domain containing 17 pseudogene (ENSG00000235993) is a nonfunctional DNA sequence located in the human genome that shares significant sequence similarity with the protein-coding gene for thioredoxin domain-containing 17. As a pseudogene, it does not encode a functional protein product and is not currently associated with any recognized biological activity or disease role. Its presence reflects prior duplication or retrotransposition of the parent gene, but mutational events have disabled its ability to produce a functional protein. While other pseudogenes have occasionally been implicated in regulatory RNA functions and disease processes, there is no evidence supporting such a mechanism for this gene. It is not considered a therapeutic target, nor is it used in drug development, biomarker studies, or clinical diagnostics.
- Other names
- Thioredoxin domain containing 17 pseudogeneTD17PTD17P1ENSG00000235993
02
Mechanism of action
None applicable (as above)
03
Biological functions
None proven. Pseudogenes in general may be transcribed but do not encode functional proteins.Some pseudogenes have regulatory RNA functions, but no such role is documented for this specific pseudogene
04
Disease associations
None documented for this pseudogene.Some pseudogenes in other families have been linked to cancer and other diseases via regulatory RNA mechanisms, but no such data exists for this target
Beyond the preview
Go deeper on Thioredoxin domain containing 17 pseudogene (TD17P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Thioredoxin domain containing 17 pseudogene (TD17P).